Accuray (NASDAQ:ARAY – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday.

NHS England has been branded 'scandalous' after it emerged that five life saving cancer machines are not being replaced ...